美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corgi U.S. Biotech 2x Daily ETF

41.75

+2.205.55%

盤後：41.66-0.0880-0.21%16:10 EDT

成交量：1,466

成交額：6.11萬

市值：83.50萬

市盈率：- -

高：41.78

開：41.67

低：41.51

收：39.55

52周最高：42.22

52周最低：25.26

股本：2.00萬

流通股本：2.00萬

量比：2.24

換手率：7.33%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

美銀證券：中國CXO行業受惠生物科技融資強勁上調藥明康德等目標價

重塑全球藥企版圖！阿斯利康擬洽購百時美施貴寶，或締造史上最大醫藥併購案

重塑全球藥企版圖！阿斯利康(AZN.US)擬洽購百時美施貴寶(BMY.US)，或締造史上最大醫藥併購案

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/XBIX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","market":"US","secType":"STK","nameCN":"Corgi U.S. Biotech 2x Daily ETF","latestPrice":41.748,"timestamp":1787688000000,"preClose":39.5522,"halted":0,"volume":1466,"hourTrading":{"tag":"盘后","latestPrice":41.66,"preClose":41.748,"latestTime":"16:10 EDT","volume":2,"amount":83.496,"timestamp":1787688604751,"change":-0.088,"changeRate":-0.002108,"amplitude":0},"delay":0,"changeRate":0.05551650729921467,"floatShares":20000,"shares":20000,"eps":0,"marketStatus":"未開盤","change":2.1958,"latestTime":"08-25 16:00:00 EDT","open":41.67,"high":41.78,"low":41.505,"amount":61133,"amplitude":0.006953,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"exchange":"CBOE","adjPreClose":39.5522,"nav":39.46,"aum":789200,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":41.66,"preClose":41.748,"latestTime":"16:10 EDT","volume":2,"amount":83.496,"timestamp":1787688604751,"change":-0.088,"changeRate":-0.002108,"amplitude":0},"volumeRatio":2.237485},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","floatShares":20000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.237485,"shares":20000,"dividePrice":0,"high":41.78,"amplitude":0.006953,"preClose":39.5522,"low":41.505,"week52Low":25.2639,"pbRate":"--","week52High":42.2188,"institutionHeld":0,"latestPrice":41.748,"eps":0,"divideRate":0,"volume":1466,"delay":0,"ttmEps":0,"open":41.67,"prevYearClose":25.42,"prevWeekClose":40.2572,"prevMonthClose":32.1639,"prevQuarterClose":37.7974,"fiveDayClose":37.7764,"twentyDayClose":33.4934},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBIX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBIX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBIX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659138517","title":"美銀證券：中國CXO行業受惠生物科技融資強勁 上調藥明康德等目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2659138517","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659138517?lang=zh_tw&edition=fundamental","pubTime":"2026-08-13 12:41","pubTimestamp":1786596060,"startTime":"0","endTime":"0","summary":"模拟交易客户端美银证券发布研报称，受惠上半年全球及中国生物科技一级市场融资表现强劲，加上创新药对外授权交易持续活跃，预期研发活动将进一步加快，中国CRO/CDMO企业可望受惠。该行上调药明康德H股目标价由204.3港元至242港元，药明康德A股目标价由177.8元人民币至210.5元人民币，维持“买入”评级，因其增长能见度清晰。该行并上调药明康德2029至2035年收入估算介乎3%至7%，经调整纯利预测亦上调介乎3%至7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-08-13/doc-inincxku3329313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","IDNA","LFSC","APXH","603259","MEDI","XBIX","BBC","FHLC","IBRN","SURI","02359","SMCO","PSIL","PSCH","BMED","WX","CXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656346866","title":"重塑全球藥企版圖！阿斯利康擬洽購百時美施貴寶，或締造史上最大醫藥併購案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656346866","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656346866?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 07:30","pubTimestamp":1785713456,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据知情人士透露，阿斯利康已就收购百时美施贵宝展开探讨，这桩超级交易若达成，将缔造全球规模最大的制药企业之一。阿斯利康市值超过百时美施贵宝百时美施贵宝正为其部分最核心产品面临专利保护到期做准备，包括抗凝药艾乐妥与抗癌药欧狄沃。两款产品合计约占百时美施贵宝销售额的一半。上周，百时美施贵宝公布季度销售额 130 亿美元，创历史最高。阿斯利康目前是伦敦证券交易所市值第二大的公司。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"重塑全球药企版图！阿斯利康拟洽购百时美施贵宝，或缔造史上最大医药并购案","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4559","AZN","LU1992135472.HKD","LU1291159041.SGD","XPH","LU2242652126.USD","LU0432979614.USD","LU2237443622.USD","LU2125154778.USD","LU2272731600.USD","LU2360032135.SGD","BK4581","LU0096364046.USD","BK4534","IE00BFTCPJ56.SGD","MEDI","LU1093756325.SGD","LU2456880835.USD","LU2237443978.SGD","SYNB","IEHS","LU1032466523.USD","IE00BJT1NW94.SGD","LU1323610961.USD","FXH","XBIX","FTXH","LU1718418525.SGD","IE00B3T34201.USD","LU2237443549.SGD","LU2473716301.USD","PILL","RXD","CURE","BMY","AZNH","LU2237443382.USD","RXL","IE0009355771.USD","LU0061475181.USD","LU0029864427.USD","LU1585245621.USD","IE00BSNM7G36.USD","PPH","FHLC","IHE","IE00B5TLWC47.USD","LU0456855351.SGD","JHMH","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656468693","title":"重塑全球藥企版圖！阿斯利康(AZN.US)擬洽購百時美施貴寶(BMY.US)，或締造史上最大醫藥併購案","url":"https://stock-news.laohu8.com/highlight/detail?id=2656468693","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656468693?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 07:25","pubTimestamp":1785713101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0058720904.USD","LU0306807586.USD","FHLC","LU2596442595.SGD","IE00BFXG1179.USD","LU2125154935.USD","PPH","FXH","LU1989771016.USD","XPH","IE0002141913.USD","BK4534","BMY","RXD","IE00B5TLWC47.USD","IE00B3T34201.USD","LU1670710661.SGD","LU0029864427.USD","IE00BJJMRZ35.SGD","LU1670711123.USD","LU1868836914.USD","LU1074936037.SGD","BK4588","AZNH","LU1032466523.USD","LU1868837136.USD","CURE","SYNB","PILL","LU2456880835.USD","LU2089984988.USD","FTXH","IHE","LU0225771236.USD","BK4581","IE0009355771.USD","LU0985481810.HKD","LU0237698245.USD","IE00BSNM7G36.USD","LU1267930573.SGD","JHMH","MEDI","IE00BFTCPJ56.SGD","LU0456855351.SGD","LU2272731782.SGD","RXL","LU0096364046.USD","XBIX","AZN","IEHS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XBIX\",params:#limit:6,delay:false,,,undefined,":[]}}